granted
on 20 Feb 2024
Last Applicant/ Owned by
400 Interpace Parkway
Parsippany
NJ
07054
Serial Number
90715573 filed on 17th May 2021
Registration Number
N/A
Correspondent Address
Laurence Rickles
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
The English translation of the word "ACUMA" in the mark is "now". Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetRead More
Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely, injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely, fertility enhancement preparations; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents affecting the central nervous system; Pharmaceutical agents affecting circulatory systems; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting urogenital organs; Pharmaceutical agents affecting peripheral nervous system
No 90715573
No Service/Collective Mark
No
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 21st Feb 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 20th Feb 2024 | SOU TEAS EXTENSION RECEIVED |
| 20th Feb 2024 | SOU EXTENSION 4 FILED |
| 20th Feb 2024 | SOU EXTENSION 4 GRANTED |
| 18th Aug 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 16th Aug 2023 | SOU TEAS EXTENSION RECEIVED |
| 16th Aug 2023 | SOU EXTENSION 3 FILED |
| 16th Aug 2023 | SOU EXTENSION 3 GRANTED |
| 16th Feb 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 14th Feb 2023 | SOU TEAS EXTENSION RECEIVED |
